載入...
Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study
OBJECTIVE: To assess the efficacy and safety of lasmiditan in the acute treatment of migraine. METHODS: Adult patients with migraine were randomized (1:1:1) to a double-blind dose of oral lasmiditan 200 mg, lasmiditan 100 mg, or placebo and were asked to treat their next migraine attack within 4 hou...
Na minha lista:
| 發表在: | Neurology |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Lippincott Williams & Wilkins
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6329326/ https://ncbi.nlm.nih.gov/pubmed/30446595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000006641 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|